| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidase activator activity | 4.79e-05 | 70 | 113 | 5 | GO:0016504 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 6.19e-05 | 38 | 113 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | arachidonate 12(S)-lipoxygenase activity | 1.89e-04 | 4 | 113 | 2 | GO:0004052 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase complex | 2.87e-04 | 5 | 113 | 2 | GO:0070418 | |
| GeneOntologyCellularComponent | myosin complex | 2.93e-04 | 59 | 113 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 3.88e-04 | 114 | 113 | 5 | GO:0005798 | |
| GeneOntologyCellularComponent | intermediate-density lipoprotein particle | 4.28e-04 | 6 | 113 | 2 | GO:0034363 | |
| GeneOntologyCellularComponent | intercalated disc | 5.05e-04 | 68 | 113 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | MLL1 complex | 6.80e-04 | 32 | 113 | 3 | GO:0071339 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 7.46e-04 | 33 | 113 | 3 | GO:0044665 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTSL1 ZAN FCGBP SEMA6D MUC17 VCAN SPARCL1 PRG4 HCFC1 CDON PCOLCE | 8.57e-04 | 656 | 113 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTSL1 ZAN FCGBP SEMA6D MUC17 VCAN SPARCL1 PRG4 HCFC1 CDON PCOLCE | 8.79e-04 | 658 | 113 | 11 | GO:0030312 |
| Domain | ARM-type_fold | DCAF1 USP34 MROH2A APOB RIF1 PSME4 XPO6 FHOD1 PRKDC WDFY3 ARMC8 | 5.15e-06 | 339 | 110 | 11 | IPR016024 |
| Domain | ARM-like | 3.14e-05 | 270 | 110 | 9 | IPR011989 | |
| Domain | - | 5.09e-05 | 222 | 110 | 8 | 1.25.10.10 | |
| Domain | Myosin_head_motor_dom | 7.21e-05 | 38 | 110 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 7.21e-05 | 38 | 110 | 4 | PS51456 | |
| Domain | Myosin_head | 7.21e-05 | 38 | 110 | 4 | PF00063 | |
| Domain | MYSc | 7.21e-05 | 38 | 110 | 4 | SM00242 | |
| Domain | TILa_dom | 1.03e-04 | 3 | 110 | 2 | IPR025615 | |
| Domain | TILa | 1.03e-04 | 3 | 110 | 2 | PF12714 | |
| Domain | LH2 | 1.52e-04 | 18 | 110 | 3 | SM00308 | |
| Domain | FERM_M | 1.54e-04 | 46 | 110 | 4 | PF00373 | |
| Domain | FERM_central | 1.97e-04 | 49 | 110 | 4 | IPR019748 | |
| Domain | FERM_domain | 1.97e-04 | 49 | 110 | 4 | IPR000299 | |
| Domain | 4_1_CTD | 2.05e-04 | 4 | 110 | 2 | PF05902 | |
| Domain | SAB | 2.05e-04 | 4 | 110 | 2 | PF04382 | |
| Domain | Band_4.1_C | 2.05e-04 | 4 | 110 | 2 | IPR008379 | |
| Domain | SAB_dom | 2.05e-04 | 4 | 110 | 2 | IPR007477 | |
| Domain | FERM_1 | 2.13e-04 | 50 | 110 | 4 | PS00660 | |
| Domain | FERM_2 | 2.13e-04 | 50 | 110 | 4 | PS00661 | |
| Domain | FERM_3 | 2.13e-04 | 50 | 110 | 4 | PS50057 | |
| Domain | Band_41_domain | 2.13e-04 | 50 | 110 | 4 | IPR019749 | |
| Domain | B41 | 2.13e-04 | 50 | 110 | 4 | SM00295 | |
| Domain | - | 2.45e-04 | 21 | 110 | 3 | 2.60.60.20 | |
| Domain | PLAT | 2.45e-04 | 21 | 110 | 3 | PF01477 | |
| Domain | PLAT/LH2_dom | 2.45e-04 | 21 | 110 | 3 | IPR001024 | |
| Domain | PLAT | 2.45e-04 | 21 | 110 | 3 | PS50095 | |
| Domain | DMAP_binding | 3.40e-04 | 5 | 110 | 2 | PF06464 | |
| Domain | FERM_CS | 3.68e-04 | 24 | 110 | 3 | IPR019747 | |
| Domain | LipOase_mml | 5.08e-04 | 6 | 110 | 2 | IPR001885 | |
| Domain | LIPOXYGENASE_1 | 5.08e-04 | 6 | 110 | 2 | PS00711 | |
| Domain | LipOase_C | 5.08e-04 | 6 | 110 | 2 | IPR013819 | |
| Domain | DMAP1-bd | 5.08e-04 | 6 | 110 | 2 | IPR010506 | |
| Domain | LIPOXYGENASE_2 | 5.08e-04 | 6 | 110 | 2 | PS00081 | |
| Domain | LipOase_Fe_BS | 5.08e-04 | 6 | 110 | 2 | IPR020833 | |
| Domain | LipOase_CS | 5.08e-04 | 6 | 110 | 2 | IPR020834 | |
| Domain | Lipoxygenase | 5.08e-04 | 6 | 110 | 2 | PF00305 | |
| Domain | LIPOXYGENASE_3 | 5.08e-04 | 6 | 110 | 2 | PS51393 | |
| Domain | LipOase | 5.08e-04 | 6 | 110 | 2 | IPR000907 | |
| Domain | DMAP_binding | 5.08e-04 | 6 | 110 | 2 | SM01137 | |
| Domain | Desmosomal_cadherin | 7.08e-04 | 7 | 110 | 2 | IPR009122 | |
| Domain | Cadherin_pro | 7.08e-04 | 7 | 110 | 2 | PF08758 | |
| Domain | Myosin_TH1 | 7.08e-04 | 7 | 110 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 7.08e-04 | 7 | 110 | 2 | IPR010926 | |
| Domain | TH1 | 7.08e-04 | 7 | 110 | 2 | PS51757 | |
| Domain | HEAT_REPEAT | 7.75e-04 | 70 | 110 | 4 | PS50077 | |
| Domain | IQ | 8.17e-04 | 71 | 110 | 4 | PF00612 | |
| Domain | Cadherin_pro | 9.40e-04 | 8 | 110 | 2 | SM01055 | |
| Domain | Cadherin_pro_dom | 9.40e-04 | 8 | 110 | 2 | IPR014868 | |
| Domain | FERM_N | 9.54e-04 | 33 | 110 | 3 | IPR018979 | |
| Domain | FERM_N | 9.54e-04 | 33 | 110 | 3 | PF09379 | |
| Domain | ZU5 | 1.20e-03 | 9 | 110 | 2 | SM00218 | |
| Domain | IQ | 1.34e-03 | 81 | 110 | 4 | SM00015 | |
| Domain | VWC | 1.44e-03 | 38 | 110 | 3 | SM00214 | |
| Domain | ZU5 | 1.50e-03 | 10 | 110 | 2 | PS51145 | |
| Domain | Fol_N | 1.83e-03 | 11 | 110 | 2 | IPR003645 | |
| Domain | FOLN | 1.83e-03 | 11 | 110 | 2 | SM00274 | |
| Domain | VWF_dom | 1.93e-03 | 42 | 110 | 3 | IPR001007 | |
| Domain | IQ_motif_EF-hand-BS | 1.97e-03 | 90 | 110 | 4 | IPR000048 | |
| Domain | C8 | 2.18e-03 | 12 | 110 | 2 | PF08742 | |
| Domain | TIL | 2.18e-03 | 12 | 110 | 2 | PF01826 | |
| Domain | ZU5 | 2.18e-03 | 12 | 110 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.18e-03 | 12 | 110 | 2 | IPR000906 | |
| Domain | IQ | 2.22e-03 | 93 | 110 | 4 | PS50096 | |
| Domain | FA | 2.57e-03 | 13 | 110 | 2 | PF08736 | |
| Domain | FERM-adjacent | 2.57e-03 | 13 | 110 | 2 | IPR014847 | |
| Domain | Unchr_dom_Cys-rich | 2.57e-03 | 13 | 110 | 2 | IPR014853 | |
| Domain | C8 | 2.57e-03 | 13 | 110 | 2 | SM00832 | |
| Domain | FA | 2.57e-03 | 13 | 110 | 2 | SM01195 | |
| Domain | Ig-like_fold | EPHB2 ADAMTSL1 HLA-DMB PSG6 LRIT3 IGHG1 VCAN MYOM2 NFAT5 HCFC1 CDON | 2.98e-03 | 706 | 110 | 11 | IPR013783 |
| Domain | TIL_dom | 2.99e-03 | 14 | 110 | 2 | IPR002919 | |
| Domain | SEA | 2.99e-03 | 14 | 110 | 2 | SM00200 | |
| Domain | - | 3.01e-03 | 49 | 110 | 3 | 1.20.80.10 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 3.19e-03 | 50 | 110 | 3 | IPR014352 | |
| Domain | - | 3.43e-03 | 15 | 110 | 2 | 3.30.70.960 | |
| Domain | p53-like_TF_DNA-bd | 3.76e-03 | 53 | 110 | 3 | IPR008967 | |
| Domain | VWF_type-D | 3.91e-03 | 16 | 110 | 2 | IPR001846 | |
| Domain | VWFD | 3.91e-03 | 16 | 110 | 2 | PS51233 | |
| Domain | VWD | 3.91e-03 | 16 | 110 | 2 | SM00216 | |
| Domain | VWD | 3.91e-03 | 16 | 110 | 2 | PF00094 | |
| Domain | FN3 | 4.78e-03 | 185 | 110 | 5 | SM00060 | |
| Domain | VWC_out | 5.51e-03 | 19 | 110 | 2 | SM00215 | |
| Domain | - | EPHB2 ADAMTSL1 HLA-DMB PSG6 LRIT3 VCAN MYOM2 NFAT5 HCFC1 CDON | 5.76e-03 | 663 | 110 | 10 | 2.60.40.10 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZNF131 SYNRG AFTPH ANK2 DSC1 HSPH1 MYO1B CCT4 ARCN1 CEP170 RIF1 MAVS FHOD1 TLN1 ELF2 PRKDC PC HCFC1 EPB41L2 TP53BP1 SON | 3.34e-12 | 934 | 114 | 21 | 33916271 |
| Pubmed | USP34 FAT4 ANK3 DSC2 LGR4 MUC16 CCT4 APOB ARCN1 TMEM263 RIF1 MAVS TMF1 PRKDC PC MGA EPB41L2 CDON | 8.56e-11 | 777 | 114 | 18 | 35844135 | |
| Pubmed | PDE1C ANK2 ANK3 MYO1D PCLO HSPH1 CCT4 ITGA2 ARCN1 CEP170 DIP2A SLC24A2 IGHG1 VCAN TLN1 MAP7D2 SLC25A11 HADH PC DAGLA EPB41L1 EPB41L2 ARMC8 | 2.27e-10 | 1431 | 114 | 23 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 DSC1 HSPH1 MYO1B CCT4 RUVBL2 ARCN1 RIF1 PSME4 IGHG1 EIF4A1 FHOD1 TLN1 MCM3AP SLC25A11 PRKDC WDFY3 MGA ALOX12B EPB41L2 TP53BP1 SON | 4.79e-10 | 1353 | 114 | 22 | 29467282 |
| Pubmed | MYO1D HSPH1 MYO1B CCT4 APOB RUVBL2 IGHG1 EIF4A1 SLC25A11 PRKDC PC | 5.51e-10 | 244 | 114 | 11 | 28902428 | |
| Pubmed | ANK2 ANK3 DSC2 HSPH1 MYO1B CCT4 RUVBL2 ARCN1 CEP170 TLN1 SLC25A11 PRKDC CRYBG3 HCFC1 EPB41L1 EPB41L2 | 1.49e-09 | 708 | 114 | 16 | 39231216 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | HSPH1 MYO1B CCT4 RUVBL2 CEP170 RIF1 SLC25A11 PRKDC MGA HCFC1 | 3.35e-09 | 221 | 114 | 10 | 29991511 |
| Pubmed | SYNRG ANK3 FNBP4 RUVBL2 ARCN1 CEP170 TLN1 SLC25A11 PRKDC PC MGA HCFC1 TP53BP1 | 3.33e-08 | 549 | 114 | 13 | 38280479 | |
| Pubmed | SYNRG ANK2 ANK3 PCLO CCT4 APP RUVBL2 ARCN1 C2CD2L CEP170 MAP7D2 SLC25A11 SPARCL1 CRYBG3 PC EPB41L1 EPB41L2 TP53BP1 | 3.39e-08 | 1139 | 114 | 18 | 36417873 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 SYNRG SPG7 C2CD2 C6orf132 C2CD2L DIP2A PSME4 XPO6 TLN1 MCM3AP DIP2C PRKDC WDFY3 PC UVRAG HCFC1 | 1.24e-07 | 1105 | 114 | 17 | 35748872 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HIVEP1 DSC1 MYO1D PCLO HSPH1 MYO1B CCT4 APOB RUVBL2 ARCN1 RIF1 EIF4A1 TLN1 SLC25A11 PRKDC PC HCFC1 EPB41L2 ARMC8 | 1.92e-07 | 1425 | 114 | 19 | 30948266 |
| Pubmed | USP34 MYO1D MYO1B CEP170 RIF1 EIF4A1 TLN1 MCM3AP PRKDC HCFC1 EPB41L2 TP53BP1 SON | 2.45e-07 | 653 | 114 | 13 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO1D MYO1B CCT4 APP RUVBL2 ARCN1 MYO5C CEP170 RIF1 IGHG1 EIF4A1 TLN1 PRKDC MGA EPB41L2 SON | 2.46e-07 | 1024 | 114 | 16 | 24711643 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.57e-07 | 444 | 114 | 11 | 34795231 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SYNRG HIVEP1 AFTPH FNBP4 RFX7 RIF1 XPO6 FHOD1 ELF2 PRKDC PRG4 EPB41L2 TP53BP1 SON | 2.61e-07 | 774 | 114 | 14 | 15302935 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ANK3 PCLO HSPH1 MYO1B CCT4 RUVBL2 ARCN1 EIF4A1 TLN1 SLC25A11 PRKDC MYO15A PC HYDIN | 4.30e-07 | 807 | 114 | 14 | 30575818 |
| Pubmed | 4.90e-07 | 288 | 114 | 9 | 38496616 | ||
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 5.10e-07 | 211 | 114 | 8 | 17314511 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | HSPH1 RUVBL2 RIF1 EIF4A1 SLC25A11 PRKDC MGA NFAT5 HCFC1 EPB41L2 TP53BP1 SON | 5.15e-07 | 583 | 114 | 12 | 29844126 |
| Pubmed | 8.28e-07 | 225 | 114 | 8 | 12168954 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SYNRG AFTPH MYO1D HSPH1 CCT4 RUVBL2 ARCN1 MAVS TLN1 MAP7D2 CEP295 SLC25A11 PC MGA | 8.30e-07 | 853 | 114 | 14 | 28718761 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 PCLO HSPH1 ARCN1 DIP2A TLN1 MCM3AP CHRD CEP295 PRKDC PWWP3B PRG4 EPB41L2 | 9.38e-07 | 736 | 114 | 13 | 29676528 |
| Pubmed | DCAF1 ZHX2 C2CD2L SEMA6D TLN1 MCM3AP FNIP1 NFAT5 EPB41L1 SON | 9.96e-07 | 407 | 114 | 10 | 12693553 | |
| Pubmed | 1.34e-06 | 105 | 114 | 6 | 9628581 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | DSC1 MYO1D HSPH1 MYO1B CCT4 ITGA2 RUVBL2 ARCN1 SLC25A11 PRKDC ALOX12B TP53BP1 | 1.53e-06 | 647 | 114 | 12 | 26618866 |
| Pubmed | DCAF1 CASP8AP2 ZNF131 AFTPH ANK2 ANK3 DSC2 HSPH1 FNBP4 APP TMEM263 DIP2A TLN1 MAP7D2 CRYBG3 EPB41L1 EPB41L2 TP53BP1 | 1.67e-06 | 1487 | 114 | 18 | 33957083 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | EPHB2 USP34 HLA-DMB HSPH1 LGR4 APOB C2CD2 RIF1 MAVS MCM3AP TMF1 GNAL PRKDC WDFY3 PC | 2.08e-06 | 1061 | 114 | 15 | 33845483 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHB2 DSC1 HSPH1 CCT4 RUVBL2 ARCN1 CEP170 FCGBP MAVS EIF4A1 TLN1 SLC25A11 PRKDC PC HCFC1 TP53BP1 SON | 2.34e-06 | 1367 | 114 | 17 | 32687490 |
| Pubmed | ANK2 HSPH1 FNBP4 MYO1B APOB RUVBL2 ARCN1 TMEM263 CEP170 RIF1 TLN1 MCM3AP SLC25A11 PC HCFC1 EPB41L2 SON | 2.43e-06 | 1371 | 114 | 17 | 36244648 | |
| Pubmed | DSC2 HSPH1 C2CD2 ARCN1 TMEM263 C2CD2L CEP170 MAVS TLN1 TMF1 HCFC1 | 2.83e-06 | 568 | 114 | 11 | 37774976 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.88e-06 | 357 | 114 | 9 | 37059091 | |
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 3.22e-06 | 270 | 114 | 8 | 24366813 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HSPH1 FNBP4 CCT4 RUVBL2 ARCN1 CEP170 RIF1 IGHG1 EIF4A1 FHOD1 TLN1 SLC25A11 PRKDC PC HCFC1 EPB41L2 SON | 3.71e-06 | 1415 | 114 | 17 | 28515276 |
| Pubmed | DCAF1 USP34 DSC2 LGR4 APP RUVBL2 C2CD2L CEP170 MCM3AP CEP295 SLC25A11 WDFY3 CRYBG3 MGA SON | 3.85e-06 | 1116 | 114 | 15 | 31753913 | |
| Pubmed | ZNF131 HIVEP1 MYO1D HSPH1 MYO1B CCT4 RFX7 ZHX2 RUVBL2 STAT4 MYO5C RIF1 ELF2 SLC25A11 MGA HCFC1 TP53BP1 | 4.23e-06 | 1429 | 114 | 17 | 35140242 | |
| Pubmed | 4.26e-06 | 128 | 114 | 6 | 23858473 | ||
| Pubmed | USP34 ANK2 ANK3 HSPH1 APP ARCN1 FAN1 DIP2A EIF4A1 PKNOX1 SPARCL1 PRKDC WDFY3 PC ZNF292 ARMC8 | 4.71e-06 | 1285 | 114 | 16 | 35914814 | |
| Pubmed | CASP8AP2 HIVEP1 ANK3 RIF1 CSN1S1 FHOD1 MCM3AP PRKDC MGA EPB41L2 | 4.82e-06 | 486 | 114 | 10 | 20936779 | |
| Pubmed | MYO1D HSPH1 CCT4 RUVBL2 TMEM263 CEP170 EIF4A1 SLC25A11 PRKDC | 5.08e-06 | 383 | 114 | 9 | 29331416 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG HIVEP1 AFTPH DSC2 RFX7 C6orf132 CEP170 FNIP1 CRYBG3 PC UVRAG EPB41L1 EPB41L2 | 5.21e-06 | 861 | 114 | 13 | 36931259 |
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 5.55e-06 | 11 | 114 | 3 | 20351715 | |
| Pubmed | DSC1 HSPH1 CCT4 RUVBL2 ARCN1 EIF4A1 FHOD1 TLN1 SLC25A11 PRKDC HADH EPB41L2 ZNF292 | 6.42e-06 | 878 | 114 | 13 | 37223481 | |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 6.43e-06 | 79 | 114 | 5 | 26446488 | |
| Pubmed | AFTPH HSPH1 RIF1 MAVS TMF1 HCFC1 EPB41L1 EPB41L2 TP53BP1 SON | 6.51e-06 | 503 | 114 | 10 | 16964243 | |
| Pubmed | 6.86e-06 | 506 | 114 | 10 | 30890647 | ||
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 7.43e-06 | 141 | 114 | 6 | 32322062 | |
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 7.73e-06 | 142 | 114 | 6 | 11812828 | |
| Pubmed | 9.58e-06 | 13 | 114 | 3 | 16368544 | ||
| Pubmed | 1.03e-05 | 87 | 114 | 5 | 12465718 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 1.06e-05 | 420 | 114 | 9 | 28065597 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23437231 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 12137943 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 31792447 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 34099188 | ||
| Pubmed | Identification and characterization of TMEM24 family genes in silico. | 1.07e-05 | 2 | 114 | 2 | 15289880 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 18802110 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 19225127 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 18815278 | ||
| Pubmed | Myosin 1b functions as an effector of EphB signaling to control cell repulsion. | 1.07e-05 | 2 | 114 | 2 | 26195670 | |
| Pubmed | Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine. | 1.07e-05 | 2 | 114 | 2 | 19845970 | |
| Pubmed | 53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy. | 1.07e-05 | 2 | 114 | 2 | 31822909 | |
| Pubmed | Differential synthesis of type 1 and type 2 desmocollin mRNAs in human stratified epithelia. | 1.07e-05 | 2 | 114 | 2 | 8507556 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 33141022 | ||
| Pubmed | A complex of the lipid transport ER proteins TMEM24 and C2CD2 with band 4.1 at cell-cell contacts. | 1.07e-05 | 2 | 114 | 2 | 39158698 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23333305 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 11781319 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 1.07e-05 | 2 | 114 | 2 | 25383926 | |
| Pubmed | Sublethal doses of β-amyloid peptide abrogate DNA-dependent protein kinase activity. | 1.07e-05 | 2 | 114 | 2 | 22139836 | |
| Pubmed | Reptin regulates DNA double strand breaks repair in human hepatocellular carcinoma. | 1.07e-05 | 2 | 114 | 2 | 25875766 | |
| Pubmed | 15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity. | 1.07e-05 | 2 | 114 | 2 | 18785202 | |
| Pubmed | 53BP1 regulates DSB repair using Rif1 to control 5' end resection. | 1.07e-05 | 2 | 114 | 2 | 23306437 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.31e-05 | 235 | 114 | 7 | 30258100 | |
| Pubmed | 1.32e-05 | 156 | 114 | 6 | 37108203 | ||
| Pubmed | A gene expression map of human chromosome 21 orthologues in the mouse. | 1.42e-05 | 158 | 114 | 6 | 12466855 | |
| Pubmed | MYO1D HSPH1 MYO1B CCT4 APP RFX7 RUVBL2 ARCN1 EIF4A1 TLN1 SLC25A11 PRKDC MGA NFAT5 HCFC1 | 1.44e-05 | 1247 | 114 | 15 | 27684187 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF131 HIVEP1 FNBP4 CEP170 RIF1 EIF4A1 ELF2 PRKDC PC MGA HCFC1 TP53BP1 SON | 1.55e-05 | 954 | 114 | 13 | 36373674 |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 1.60e-05 | 558 | 114 | 10 | 35063084 | |
| Pubmed | 1.70e-05 | 163 | 114 | 6 | 12466854 | ||
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | MYO1D HSPH1 MYO1B CCT4 RUVBL2 IGHG1 EIF4A1 SLC25A11 PRKDC PC | 1.78e-05 | 565 | 114 | 10 | 33567341 |
| Pubmed | 1.80e-05 | 449 | 114 | 9 | 31732153 | ||
| Pubmed | 1.86e-05 | 16 | 114 | 3 | 20805357 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.87e-05 | 344 | 114 | 8 | 30333137 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | CCT4 RUVBL2 ARCN1 EIF4A1 SLC25A11 PRKDC PC HCFC1 EPB41L2 TP53BP1 SON | 2.11e-05 | 704 | 114 | 11 | 29955894 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.16e-05 | 351 | 114 | 8 | 38297188 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DCAF1 DSC1 HSPH1 MYO1B CCT4 RUVBL2 RIF1 EIF4A1 PRKDC PC HCFC1 TP53BP1 SON | 2.25e-05 | 989 | 114 | 13 | 36424410 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.27e-05 | 256 | 114 | 7 | 33397691 | |
| Pubmed | 2.33e-05 | 257 | 114 | 7 | 16335952 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 CASP8AP2 SYNRG HIVEP1 MYO1D MYO1B RUVBL2 MCM3AP CRYBG3 TP53BP1 | 2.49e-05 | 588 | 114 | 10 | 38580884 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 2.89e-05 | 477 | 114 | 9 | 31300519 | |
| Pubmed | 2.90e-05 | 266 | 114 | 7 | 19380743 | ||
| Pubmed | AFTPH HSPH1 CCT4 APP ZHX2 C6orf132 C2CD2L RIF1 EIF4A1 TLN1 TMF1 SLC25A11 EPB41L1 EPB41L2 SON ARMC8 | 3.09e-05 | 1497 | 114 | 16 | 31527615 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 11050113 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 20824083 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 24808370 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 15611082 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 21526938 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 17236128 | ||
| Pubmed | Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. | 3.19e-05 | 3 | 114 | 2 | 11067913 | |
| Pubmed | Islet antigen-specific Th17 cells can induce TNF-α-dependent autoimmune diabetes. | 3.19e-05 | 3 | 114 | 2 | 24446517 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 17203969 | ||
| Interaction | NAA40 interactions | ZNF131 SYNRG AFTPH ANK2 DSC1 HSPH1 MYO1B CCT4 ARCN1 CEP170 RIF1 MAVS FHOD1 TLN1 ELF2 PRKDC PC HCFC1 EPB41L2 TP53BP1 SON | 1.03e-07 | 978 | 113 | 21 | int:NAA40 |
| Interaction | KCNA3 interactions | ANK2 ANK3 DSC2 MYO1D HSPH1 MYO1B CCT4 RUVBL2 ARCN1 MYO5C CEP170 EIF4A1 TLN1 SLC25A11 PRKDC CRYBG3 HCFC1 EPB41L1 EPB41L2 | 3.58e-07 | 871 | 113 | 19 | int:KCNA3 |
| Interaction | FLOT1 interactions | ANK2 ANK3 DSC2 MYO1D PCLO MYO1B CCT4 APP STAT4 ELF2 SLC25A11 CRYBG3 EPB41L1 EPB41L2 | 4.40e-07 | 475 | 113 | 14 | int:FLOT1 |
| Interaction | TOP3B interactions | USP34 SYNRG SPG7 MYO1D MYO1B APOB APP C2CD2 C6orf132 C2CD2L DIP2A PSME4 XPO6 EIF4A1 TLN1 MCM3AP DIP2C SLC25A11 PRKDC WDFY3 PC UVRAG HCFC1 TP53BP1 | 1.67e-06 | 1470 | 113 | 24 | int:TOP3B |
| Interaction | NUP43 interactions | DCAF1 USP34 CASP8AP2 ZNF131 HIVEP1 DSC1 ZHX2 RIF1 MAVS MCM3AP ELF2 MGA HCFC1 SON ZNF292 | 2.18e-06 | 625 | 113 | 15 | int:NUP43 |
| Interaction | KCTD13 interactions | PDE1C ANK2 ANK3 MYO1D PCLO HSPH1 CCT4 ITGA2 ARCN1 CEP170 DIP2A SLC24A2 VCAN TLN1 MAP7D2 SLC25A11 HADH PC DAGLA EPB41L1 EPB41L2 ARMC8 | 8.46e-06 | 1394 | 113 | 22 | int:KCTD13 |
| Interaction | NEXN interactions | 1.23e-05 | 91 | 113 | 6 | int:NEXN | |
| Interaction | UCHL5 interactions | 1.26e-05 | 319 | 113 | 10 | int:UCHL5 | |
| Interaction | EPB41L4A interactions | 1.40e-05 | 140 | 113 | 7 | int:EPB41L4A | |
| Interaction | SIRT7 interactions | DCAF1 USP34 MYO1D MYO1B APP CEP170 RIF1 EIF4A1 TLN1 MCM3AP PRKDC HCFC1 EPB41L2 TP53BP1 SON | 1.76e-05 | 744 | 113 | 15 | int:SIRT7 |
| Interaction | MYH9 interactions | DCAF1 HIVEP1 HSPH1 LGR4 MYO1B APOB RUVBL2 C2CD2 ARCN1 MYO5C TLN1 PKNOX1 MYOM2 CCDC180 EPB41L2 | 2.06e-05 | 754 | 113 | 15 | int:MYH9 |
| Interaction | FLCN interactions | 2.11e-05 | 100 | 113 | 6 | int:FLCN | |
| Interaction | ASXL2 interactions | 2.64e-05 | 277 | 113 | 9 | int:ASXL2 | |
| Interaction | ELF2 interactions | 2.83e-05 | 156 | 113 | 7 | int:ELF2 | |
| Interaction | YAP1 interactions | ANK3 MYO1D HSPH1 FNBP4 MYO1B CCT4 RUVBL2 CEP170 EIF4A1 TLN1 SLC25A11 PRKDC PC MGA NFAT5 UVRAG HCFC1 EPB41L2 | 3.71e-05 | 1095 | 113 | 18 | int:YAP1 |
| Interaction | TRIM40 interactions | 4.71e-05 | 13 | 113 | 3 | int:TRIM40 | |
| Interaction | PLA2G4C interactions | 4.71e-05 | 13 | 113 | 3 | int:PLA2G4C | |
| Interaction | RPA4 interactions | USP34 APP RUVBL2 CEP170 RIF1 PSME4 TLN1 SLC25A11 HCFC1 EPB41L2 SON | 4.77e-05 | 452 | 113 | 11 | int:RPA4 |
| Interaction | SETD1A interactions | 4.90e-05 | 170 | 113 | 7 | int:SETD1A | |
| Interaction | ITGB3 interactions | 4.90e-05 | 170 | 113 | 7 | int:ITGB3 | |
| Interaction | ARL5A interactions | 5.38e-05 | 118 | 113 | 6 | int:ARL5A | |
| Interaction | YWHAG interactions | SYNRG HIVEP1 AFTPH DSC2 HSPH1 LGR4 APP RFX7 RUVBL2 C6orf132 C2CD2L CEP170 IGHG1 FNIP1 PRKDC UVRAG EPB41L1 EPB41L2 SON | 6.22e-05 | 1248 | 113 | 19 | int:YWHAG |
| Interaction | C11orf52 interactions | 6.48e-05 | 311 | 113 | 9 | int:C11orf52 | |
| Interaction | AGR2 interactions | ZNF131 ANK3 PCLO HSPH1 MYO1B CCT4 APP RUVBL2 ARCN1 EIF4A1 TLN1 SLC25A11 PRKDC MYO15A PC HYDIN | 6.49e-05 | 934 | 113 | 16 | int:AGR2 |
| Interaction | NRSN1 interactions | 6.79e-05 | 179 | 113 | 7 | int:NRSN1 | |
| Interaction | GRWD1 interactions | HSPH1 MYO1B CCT4 RUVBL2 CEP170 RIF1 SLC25A11 PRKDC MGA HCFC1 | 6.94e-05 | 390 | 113 | 10 | int:GRWD1 |
| Interaction | RFWD3 interactions | 8.72e-05 | 80 | 113 | 5 | int:RFWD3 | |
| Interaction | GABPA interactions | 9.22e-05 | 130 | 113 | 6 | int:GABPA | |
| Interaction | TRIM52 interactions | 1.05e-04 | 133 | 113 | 6 | int:TRIM52 | |
| Interaction | AATK interactions | 1.12e-04 | 194 | 113 | 7 | int:AATK | |
| Interaction | PPIA interactions | ZNF131 AFTPH ANK3 APP CEP170 RIF1 MAVS EIF4A1 FHOD1 KLHL15 CRYBG3 UVRAG HCFC1 TP53BP1 ARMC8 | 1.31e-04 | 888 | 113 | 15 | int:PPIA |
| Interaction | BTF3 interactions | ANK2 ANK3 MYO1D HSPH1 MYO1B CCT4 APP RUVBL2 TMEM263 CEP170 IGHG1 EIF4A1 PRKDC NFAT5 | 1.53e-04 | 799 | 113 | 14 | int:BTF3 |
| Interaction | YWHAQ interactions | SYNRG AFTPH DSC2 HSPH1 APP RFX7 ZHX2 RUVBL2 C6orf132 CEP170 IGHG1 TLN1 PRKDC PC UVRAG EPB41L1 EPB41L2 | 1.61e-04 | 1118 | 113 | 17 | int:YWHAQ |
| Interaction | ARL4D interactions | 1.74e-04 | 146 | 113 | 6 | int:ARL4D | |
| Interaction | RNF123 interactions | FAT4 PCLO HSPH1 APP ARCN1 DIP2A TLN1 MCM3AP CHRD CEP295 PRKDC PWWP3B PRG4 EPB41L2 | 2.10e-04 | 824 | 113 | 14 | int:RNF123 |
| Interaction | ZFPL1 interactions | ANK3 DSC2 MYO1B ARCN1 C2CD2L MAVS IGHG1 TMF1 EPB41L1 EPB41L2 | 2.15e-04 | 448 | 113 | 10 | int:ZFPL1 |
| Interaction | EPHB2 interactions | 2.18e-04 | 216 | 113 | 7 | int:EPHB2 | |
| Interaction | PML interactions | USP34 CASP8AP2 SYNRG MYO1D APP ZHX2 CEP170 MAVS FHOD1 TLN1 ELF2 PC HCFC1 EPB41L2 TP53BP1 | 2.24e-04 | 933 | 113 | 15 | int:PML |
| Interaction | TFCP2L1 interactions | 2.38e-04 | 99 | 113 | 5 | int:TFCP2L1 | |
| Interaction | YY1 interactions | 2.39e-04 | 454 | 113 | 10 | int:YY1 | |
| Interaction | RBX1 interactions | DCAF1 HSPH1 APP RUVBL2 MYO5C EIF4A1 KLHL15 PRKDC PC UVRAG SON | 3.02e-04 | 558 | 113 | 11 | int:RBX1 |
| Interaction | KLF3 interactions | 3.03e-04 | 228 | 113 | 7 | int:KLF3 | |
| Interaction | HCFC1R1 interactions | 3.08e-04 | 5 | 113 | 2 | int:HCFC1R1 | |
| Interaction | TNKS interactions | 3.13e-04 | 105 | 113 | 5 | int:TNKS | |
| Cytoband | 21q22.3 | 3.03e-04 | 128 | 114 | 4 | 21q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q25 | 1.55e-03 | 91 | 114 | 3 | chr4q25 | |
| Cytoband | 18q12.1 | 1.91e-03 | 26 | 114 | 2 | 18q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 2.57e-03 | 377 | 114 | 5 | chr21q22 | |
| Cytoband | 2p15 | 2.71e-03 | 31 | 114 | 2 | 2p15 | |
| Cytoband | 7q22 | 4.05e-03 | 38 | 114 | 2 | 7q22 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 5.73e-05 | 50 | 76 | 4 | 1293 | |
| GeneFamily | Erythrocyte membrane protein band 4.1|FERM domain containing | 1.04e-04 | 4 | 76 | 2 | 951 | |
| GeneFamily | Arachidonate lipoxygenases | 2.59e-04 | 6 | 76 | 2 | 407 | |
| GeneFamily | Desmosomal cadherins | 3.61e-04 | 7 | 76 | 2 | 1188 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.61e-04 | 36 | 76 | 3 | 823 | |
| GeneFamily | Myosins, class I | 4.80e-04 | 8 | 76 | 2 | 1097 | |
| GeneFamily | CD molecules|Mucins | 3.48e-03 | 21 | 76 | 2 | 648 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.73e-03 | 161 | 76 | 4 | 593 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 USP34 HIVEP1 MYO1B APP ZHX2 C2CD2 CEP170 RIF1 PSME4 XPO6 WDFY3 CRYBG3 UVRAG TP53BP1 SON ZNF292 | 1.79e-07 | 856 | 114 | 17 | M4500 |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ZNF131 ANK3 CCT4 RUVBL2 CEP170 MAVS GVINP1 IGHG1 PKNOX1 ELF2 SLC25A11 ARMC8 | 1.14e-06 | 475 | 114 | 12 | M40979 |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 2.63e-05 | 198 | 114 | 7 | M6089 | |
| Coexpression | GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 2.71e-05 | 199 | 114 | 7 | M9567 | |
| Coexpression | KYNG_WERNER_SYNDROM_UP | 2.82e-05 | 14 | 114 | 3 | M1996 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-11 | 184 | 114 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-11 | 184 | 114 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-11 | 184 | 114 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ANK3 MYO1D PCLO MUC16 ITGA2 APP C6orf132 SPARCL1 EPB41L1 ALOX15 | 1.09e-10 | 200 | 114 | 10 | ecbe89ff95d046155b984c8c150e0b9e7278f839 |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.45e-09 | 200 | 114 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-08 | 195 | 114 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-08 | 195 | 114 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.69e-08 | 199 | 114 | 8 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.63e-07 | 168 | 114 | 7 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-07 | 188 | 114 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-07 | 189 | 114 | 7 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.69e-07 | 193 | 114 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-07 | 193 | 114 | 7 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.17e-07 | 195 | 114 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.22e-07 | 199 | 114 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.50e-07 | 200 | 114 | 7 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-06 | 175 | 114 | 6 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.60e-06 | 178 | 114 | 6 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.81e-06 | 179 | 114 | 6 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-06 | 185 | 114 | 6 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.22e-06 | 185 | 114 | 6 | 405bd4ba7ca7f7b625c49f1313ff946509e17c13 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-06 | 185 | 114 | 6 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-06 | 185 | 114 | 6 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.22e-06 | 185 | 114 | 6 | 2aa5e9f6f167d27317a01d22392b59512333fa64 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.74e-06 | 187 | 114 | 6 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 187 | 114 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-06 | 189 | 114 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-06 | 189 | 114 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 9.57e-06 | 190 | 114 | 6 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.57e-06 | 190 | 114 | 6 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-06 | 191 | 114 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-06 | 191 | 114 | 6 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-06 | 191 | 114 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-06 | 191 | 114 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-05 | 192 | 114 | 6 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.02e-05 | 192 | 114 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.05e-05 | 193 | 114 | 6 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 193 | 114 | 6 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 193 | 114 | 6 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-05 | 193 | 114 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | background-Cholangiocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-05 | 193 | 114 | 6 | 9152241073dbe02ac2c11d86bec9b5b529196f6e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-05 | 194 | 114 | 6 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.08e-05 | 194 | 114 | 6 | 784b15119c91ace33d34bfb3d68c182566a3e9a8 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.11e-05 | 195 | 114 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.11e-05 | 195 | 114 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.14e-05 | 196 | 114 | 6 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | 368C|World / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-05 | 197 | 114 | 6 | f41211923938e5d7bfe6bf24f604ab386f17ef10 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 198 | 114 | 6 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | 15-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 1.21e-05 | 198 | 114 | 6 | e87d1fe2befbd32b0c723ab43b9de95495ea3ee3 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 1.25e-05 | 199 | 114 | 6 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 1.25e-05 | 199 | 114 | 6 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-intermediate_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.25e-05 | 199 | 114 | 6 | f9e3fb974ba8fe1b6d99892577549ef143df9e08 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.25e-05 | 199 | 114 | 6 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.25e-05 | 199 | 114 | 6 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-05 | 199 | 114 | 6 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-05 | 199 | 114 | 6 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.28e-05 | 200 | 114 | 6 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.28e-05 | 200 | 114 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.28e-05 | 200 | 114 | 6 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.28e-05 | 200 | 114 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.28e-05 | 200 | 114 | 6 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.28e-05 | 200 | 114 | 6 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 200 | 114 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Ebf1_(Anterior_pretectal_nucleus_(APT))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.39e-05 | 57 | 114 | 4 | ef44602342511a9f90c93463628ad8b154cb26fb | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Ebf1_(Anterior_pretectal_nucleus_(APT))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.39e-05 | 57 | 114 | 4 | a3dc14f7a63cc70b2789770644e0b9453426c6f9 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-05 | 133 | 114 | 5 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.92e-05 | 74 | 114 | 4 | c68b00cf7d2cec7951b78e2c6710d7770b02566a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.92e-05 | 74 | 114 | 4 | bad24c9251ef44c05f3390073732a467aaeefe1e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.92e-05 | 74 | 114 | 4 | 195fd37345a394c0b60f713bedadf6fd08dc050c | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 4.50e-05 | 152 | 114 | 5 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 5.09e-05 | 156 | 114 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 5.09e-05 | 156 | 114 | 5 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 5.41e-05 | 158 | 114 | 5 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / disease group, cell group and cell class | 5.57e-05 | 159 | 114 | 5 | 9e2067f0d76769717f7048dab505fadd36bbb83e | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 5.91e-05 | 161 | 114 | 5 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.45e-05 | 164 | 114 | 5 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-05 | 167 | 114 | 5 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-05 | 167 | 114 | 5 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 7.03e-05 | 167 | 114 | 5 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.64e-05 | 170 | 114 | 5 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.64e-05 | 170 | 114 | 5 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.30e-05 | 173 | 114 | 5 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.30e-05 | 173 | 114 | 5 | 3d7c281a1a9f183a5a861d1a9c7b50d216535893 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.30e-05 | 173 | 114 | 5 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 8.30e-05 | 173 | 114 | 5 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.30e-05 | 173 | 114 | 5 | 3aa90578371039f81b7c6fa873ec70f8f2bc7dfa | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.53e-05 | 174 | 114 | 5 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.24e-05 | 177 | 114 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-05 | 177 | 114 | 5 | e5070934c674a46e070b0d52b9a374516bf6aea1 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-05 | 177 | 114 | 5 | b37d821f4f3204daf7c568ac17a0af0ba97273d6 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.49e-05 | 178 | 114 | 5 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.49e-05 | 178 | 114 | 5 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.75e-05 | 179 | 114 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.00e-04 | 180 | 114 | 5 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 181 | 114 | 5 | 35eefd874a892eaf21f24fdce89e7ea3b8ee285f | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.03e-04 | 181 | 114 | 5 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 181 | 114 | 5 | e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968 | |
| Computational | Neighborhood of RAD54L | 6.97e-05 | 105 | 72 | 6 | MORF_RAD54L | |
| Computational | Neighborhood of CDK2 | 1.16e-04 | 72 | 72 | 5 | MORF_CDK2 | |
| Computational | Neighborhood of PRKDC | 2.78e-04 | 191 | 72 | 7 | MORF_PRKDC | |
| Computational | Neighborhood of CDC10 | 4.24e-04 | 146 | 72 | 6 | MORF_CDC10 | |
| Computational | Neighborhood of HDAC2 | 5.41e-04 | 280 | 72 | 8 | MORF_HDAC2 | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; PC3; HT_HG-U133A | 6.43e-07 | 196 | 114 | 9 | 5812_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 7.30e-07 | 199 | 114 | 9 | 5283_DN | |
| Drug | B0683 | 2.06e-06 | 117 | 114 | 7 | CID006398969 | |
| Drug | formycin triphosphate | 5.63e-06 | 51 | 114 | 5 | CID000122274 | |
| Disease | chronotype measurement | USP34 PDE1C HIVEP1 ANK2 ANK3 FNBP4 SEMA6D NXF5 DIP2C TMEM108 PC JHY | 1.35e-04 | 882 | 112 | 12 | EFO_0008328 |
| Disease | arrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology) | 1.42e-04 | 5 | 112 | 2 | DOID:0050431 (implicated_via_orthology) | |
| Disease | response to stress, systolic blood pressure change measurement | 1.42e-04 | 5 | 112 | 2 | EFO_0006944, GO_0006950 | |
| Disease | desmocollin-2 measurement | 1.42e-04 | 5 | 112 | 2 | EFO_0021936 | |
| Disease | Adenoid Cystic Carcinoma | 5.83e-04 | 100 | 112 | 4 | C0010606 | |
| Disease | Drug habituation | 9.84e-04 | 115 | 112 | 4 | C0013170 | |
| Disease | Drug abuse | 9.84e-04 | 115 | 112 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 9.84e-04 | 115 | 112 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 9.84e-04 | 115 | 112 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 9.84e-04 | 115 | 112 | 4 | C0013222 | |
| Disease | Drug Dependence | 9.84e-04 | 115 | 112 | 4 | C1510472 | |
| Disease | Substance Dependence | 9.84e-04 | 115 | 112 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 9.84e-04 | 115 | 112 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 9.84e-04 | 115 | 112 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.02e-03 | 116 | 112 | 4 | C0740858 | |
| Disease | plasminogen activator inhibitor 1 measurement | 1.15e-03 | 54 | 112 | 3 | EFO_0004792 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.34e-03 | 57 | 112 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | response to statin, LDL cholesterol change measurement | 1.45e-03 | 15 | 112 | 2 | EFO_0007804, GO_0036273 | |
| Disease | lysophosphatidylcholine measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0010224 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.87e-03 | 17 | 112 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | sporadic amyotrophic lateral sclerosis | 2.03e-03 | 140 | 112 | 4 | EFO_0001357 | |
| Disease | hair colour measurement | 2.43e-03 | 615 | 112 | 8 | EFO_0007822 | |
| Disease | nicotine dependence | 3.29e-03 | 78 | 112 | 3 | EFO_0003768 | |
| Disease | R-warfarin measurement | 3.46e-03 | 265 | 112 | 5 | EFO_0803324 | |
| Disease | Behcet Syndrome | 3.73e-03 | 24 | 112 | 2 | C0004943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEVPIVKTSSMEISS | 1461 | Q5SW79 | |
| LTSSPEDILMVTKDV | 76 | Q6DHV7 | |
| SEPIHVTESSVEMTK | 731 | P13611 | |
| ISPETMRTTKITEGT | 1016 | P13611 | |
| AATKILSEVTRPMSV | 91 | Q49AH0 | |
| ETIGATVSTPSVIEM | 1831 | Q68DQ2 | |
| TVSTPSVIEMEKISP | 1836 | Q68DQ2 | |
| DALMPSLTETKTTVE | 591 | P05067 | |
| PEITLASTVAETMLS | 586 | Q8IZF6 | |
| VLLSTTSKEIISSEM | 106 | Q6ULP2 | |
| KEIEASAEVSPTTMT | 136 | Q8NEB7 | |
| LKEVSTVIVVLMSAS | 1136 | Q7Z2Y8 | |
| QPSLSSSTEVVVMVL | 2131 | Q6V0I7 | |
| LMDTIVPEKISTSTF | 156 | Q9P1Z9 | |
| VMSTSSLEKIVPIIA | 1016 | Q9UKL3 | |
| TVIICKPTMSSAEIV | 581 | Q02487 | |
| SLVVTATVKSMVREP | 336 | Q15113 | |
| SPTSKTERIEETMSV | 1976 | Q01484 | |
| TVLSVPAGTTIVKTM | 566 | P51610 | |
| TTIIKTIPMSAIITQ | 766 | P51610 | |
| GIKSPITIITTKVMT | 791 | P51610 | |
| LVETTDGTLVTTIKM | 3156 | Q8WXI7 | |
| ETPKATTQMVITTTV | 5146 | Q8WXI7 | |
| ESTMLPEISTTRKII | 7296 | Q8WXI7 | |
| PILAESSEMTIKTQT | 7316 | Q8WXI7 | |
| TTIPASSEITRIEME | 8981 | Q8WXI7 | |
| SDEVVTRLSTSPIMT | 9641 | Q8WXI7 | |
| SPIMTESAEITITTQ | 9651 | Q8WXI7 | |
| VEIPATSEIMTDTEK | 9791 | Q8WXI7 | |
| DQSTMSPDIITEVIT | 9926 | Q8WXI7 | |
| TATVLTKEADLPMTA | 866 | Q9Y4B6 | |
| QFEPVKTETMTVSSL | 691 | Q9H4G0 | |
| VITPEMLVVLSTEKT | 76 | P58181 | |
| SMVLTKVSASTVPTD | 366 | Q7Z434 | |
| DTSTKPESIVIMHAS | 406 | Q6NUN7 | |
| SMDVSPVSKEELISI | 646 | Q96T17 | |
| AVTPMTAISDVETKE | 1611 | Q8IWI9 | |
| MTEVVPSSALSEVSL | 1 | Q9H7X0 | |
| VTETMREKIFTPLTV | 1531 | Q9UKN7 | |
| TIAVNMTKTLPTAVT | 11 | Q7Z3F1 | |
| VEVIKTPMTSQKTFE | 181 | Q16836 | |
| LSHTIEPVMKTSVTT | 1911 | O60318 | |
| TISTASMVEKVPTEE | 491 | Q92598 | |
| VVAEPEKMESSISSS | 76 | P47710 | |
| SRMTVINTEKPAVTV | 1276 | Q8N6G6 | |
| PVVKTEMVTISDASQ | 871 | O43491 | |
| EGVVTKSTPVMIITE | 686 | P29323 | |
| LLSATMPSDVLEVTK | 211 | P60842 | |
| LSDMASSIIESVVPK | 2266 | Q9Y6V0 | |
| TSSVMTKIIEDEKPV | 2916 | Q9Y6V0 | |
| SAPVIVDIDSSETMK | 251 | Q9H1B4 | |
| EPTFTVLTDMTEKIV | 436 | Q14123 | |
| PTTKDATLETVMATL | 566 | P16050 | |
| LITAISISPEIMKSV | 771 | Q9BXB1 | |
| MSEAVVTVTVLGITT | 336 | Q3SXY7 | |
| KVTTGSVPVSMATVI | 976 | P17301 | |
| DVTPMEVTAEKRSST | 606 | O94916 | |
| LVTTAASMPVDIAKT | 231 | Q02978 | |
| VKDAIVTIVSAMSTI | 86 | P38405 | |
| TTLPTTTSQLMAEKD | 696 | Q5T0Z8 | |
| MEVSVATTTKAQIPI | 3421 | P04114 | |
| ETPIRMSVLSEVTAS | 6 | Q8IUR7 | |
| LSPMQTLKVSVSAVT | 211 | P28068 | |
| TLVITNKEETPMSID | 4336 | Q4G0P3 | |
| TVSIATMPTHSIKTE | 146 | Q9NZI5 | |
| LMTPTSVFEKVKTSE | 226 | Q96M94 | |
| KDRTVMPCGTVVTTV | 406 | Q9Y426 | |
| MPCGTVVTTVTAVKT | 411 | Q9Y426 | |
| DRTIMPDGTIVTTVT | 436 | O14523 | |
| TSKKVTVRPGESVMV | 76 | Q9Y6R7 | |
| AIVMPGTVITTTLEK | 561 | Q8TF40 | |
| MVVPFETNTKAETVT | 516 | Q4KMG0 | |
| ATTLPTVKMIVEVSR | 1066 | Q9Y2E4 | |
| LRAESEVPIVKTSSM | 166 | Q96L14 | |
| EVPIVKTSSMEISSI | 171 | Q96L14 | |
| VVDTLKIVTEETMTT | 811 | Q12955 | |
| MRPDVITETVVEVST | 136 | Q15723 | |
| TLETFMDTLPDVKTT | 611 | O75342 | |
| TALLSAAKVMVSPTE | 671 | Q9Y4D2 | |
| PTMCTTTVTVKIIDS | 451 | Q08554 | |
| KDTLMISRTPEVTCV | 131 | P01857 | |
| GTTLPTVKMIVEVSK | 1081 | Q14689 | |
| EIMDLLVQSVTKSSP | 1106 | Q9Y613 | |
| SEMITTVSEIESKAP | 411 | Q9C0D2 | |
| TAAMITETIIETDKP | 196 | P48444 | |
| MKVASSEAITLLTTP | 226 | Q685J3 | |
| PETISAQMELTVTVT | 4181 | Q685J3 | |
| SVIIMEKATTEPSVV | 66 | A6NES4 | |
| MVDLTSVTLEDVTPK | 86 | Q9Y2M0 | |
| MATVTATTKVPEIRD | 1 | Q9Y230 | |
| VTTVPSMGETERKIT | 531 | Q9P2Y5 | |
| EVSVVVSLVTMIAPS | 361 | Q7Z5M5 | |
| ILETTMTPTGIDTAK | 306 | Q9UMZ2 | |
| TVEEATTIVKPQEIM | 361 | Q8N3X1 | |
| KIELPNSTSTDVEMT | 411 | Q9UI40 | |
| ELTMSEGAVVTITTP | 361 | P55347 | |
| APTMVDTIPSEVETK | 171 | Q5H9M0 | |
| KSMIVKVSETASPQV | 406 | Q00889 | |
| EVFPVSKTLVLMEIT | 541 | Q5UIP0 | |
| VMTITKLTQKPSEFT | 756 | Q9NTG1 | |
| VMKVIDPATATSVDL | 191 | P50991 | |
| EHTEAVMKVSITPRT | 586 | Q9UQ90 | |
| TITTTEIMNKPEETA | 991 | Q92954 | |
| EVTKTAVTTVPSMGI | 66 | Q8WUH6 | |
| TSSEVVAMTLETKPQ | 446 | Q9H2X0 | |
| DMKVPTVSLKVSESV | 186 | P82094 | |
| VSESVIDVKTTMESI | 196 | P82094 | |
| TVPLTRVKCLVSMTT | 1016 | Q8IZQ1 | |
| VTVQEMVTKSNTSPE | 1866 | Q9Y490 | |
| TIDLETSSLPVVMIS | 441 | Q14765 | |
| TEEKTVSEALLMEPT | 311 | Q14515 | |
| VSMGAVSKETPVVTI | 166 | Q2M296 | |
| STADITVIQPVSEMI | 1876 | O60281 | |
| SSLNVVKMTTISLTP | 371 | Q2KHR2 | |
| MEVETSVISIDSPQK | 716 | Q12888 | |
| VTNLVPSMVSLEETK | 836 | Q14997 | |
| PEETLSLMTKEISSV | 3476 | P78527 | |
| KSTTPCMVRTSQVVE | 6 | Q9Y6X8 | |
| PEQRTSSMVSEVKTI | 356 | Q969Z4 | |
| SVETRVQTEPVTSMT | 456 | P52739 | |
| DMKTETREVLTPTST | 3371 | Q70CQ2 | |
| VTTPLGLIMLKTTSE | 141 | Q96QU8 | |
| TTMDAITPLISTKVQ | 656 | Q96QU8 | |
| SVTTMASIPEITPKV | 596 | Q8NFY4 | |
| ETVVTSPMEGTVRKV | 1146 | P11498 | |
| VTSATLPTKLIDSMS | 1596 | P15822 | |
| AVTVAMELTEQPVTT | 496 | P18583 | |
| MIVSEPSVSVQESTV | 1431 | P18583 | |
| KEETVATLTMTDRVP | 401 | Q6UXF1 | |
| IPTEKPTISMEETII | 691 | Q9Y493 | |
| KSEVPLVDVTKVSMS | 1026 | O43795 | |
| VVSIIAELLSTKTDM | 296 | O94832 | |
| RKIVTSSETVVKPMT | 376 | Q9NQX4 | |
| EGETVTLKCTMLVTP | 291 | P54296 |